XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.1
LICENSE PURCHASED
9 Months Ended
Apr. 30, 2022
License Purchased  
LICENSE PURCHASED

 

Note 7 LICENSE PURCHASED

 

On April 11, 2022, the Company, through its wholly owned subsidiary DSI, acquired an exclusive license to distribute in the USA, Canada and Mexico, certain intellectual property in animal nutrition and animal supplements from Cedoga Consulting, LLC. The Company receives 10% of all licensing fees due to Cedoga in exchange for 300,000 post reverse split shares of common stock of the Company. Under the terms of the agreement, the Company will pay royalties from sub-licensing on the following basis:

 

90% of net royalties for sale and initial payments up to $100,000,000 per calendar year.

 

95% of net royalties received for continuing sales above $100,000,000 per calendar year.

 

90% of any lump up-front payment sub-licensing fees.

 

Option to purchase 200,000 shares of the Company’s common stock when net sales exceed $100,000,000.